Fund Holdings — SABBY MANAGEMENT, LLC

Total Portfolio Value
$12.02M
Total Bought
$9.42M
Total Sold
$3.01M
Net Transaction
+$6.41M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
TOYO CO LTD(TOYO)0503,846+503,84603,50229.13%+3,502
STATE STREET SPDR S&P(SPY)2,7345,500+2,7661,7784,10734.17%+2,329
FARMMI INC(FAMI)03,515,929+3,515,92908406.99%+840
CERVOMED INC(CRVO)0248,880+248,88007726.42%+772
PARANOVUS ENTERTNMNT TECH LT075,440+75,44005614.66%+561
TEMPEST THERAPEUTICS INC(TPST)17,856511,286+493,430295684.72%+538
BIOAFFINITY TECHNOLOGIES(BIAF)0365,647+365,64702972.47%+297
SMART POWER CORP0127,774+127,77402632.19%+263
SIDUS SPACE INC(SIDU)043,377+43,37701221.01%+122
REVELATION BIOSCIENCES INC(REVB)99,432210,582+111,1501192171.80%+98
NUWELLIS INC016,372+16,3720500.42%+50
BNB PLUS CORP(BNBX)13,5410-13,54190—-9
BRIACELL THERAPEUTICS CORP(BCTX)206,753120,802-85,95129110.10%-17
BRIACELL THERAPEUTICS CORP(BCTX)73,91580,721+6,8063102622.18%-48
LYRA THERAPEUTICS INC104,0590-104,059510—-51
BLUEJAY DIAGNOSTICS INC28,7260-28,726530—-53
INMED PHARMACEUTICALS(INM)220,26044,970-175,290142700.58%-72
CALIDI BIOTHERAPEUTICS INC(CLDI)434,9030-434,9031040—-104
CHINA SXT PHARMACEUTICALS INC
USD CL A ORD SHS
78,1700-78,1701310—-131
CAN FITE BIOFARMA LTD(CANF)42,5590-42,5591320—-132
SENESTECH INC(SNES)218,533141,756-76,7773582111.76%-147
TRX GOLD CORP(TRX)100,0000-100,0001500—-150
ARCADIA BIOSCIENCES INC114,5540-114,5541580—-158
BIODEXA PHARMACEUTICALS PLC(BDRX)257,4720-257,4721590—-159
MOLECULIN BIOTECH INC(MBRX)75,0210-75,0211720—-172
POP CULTURE GROUP CO LTD(CPOP)664,4490-664,4492010—-201
BRIACELL THERAPEUTICS CORP(BCTX)380,686190,383-190,3033921691.41%-223
TOKEN CAT LTD(TC)23,2390-23,2392420—-242
BIG TREE CLOUD HLDGS LTD(DSY)137,6110-137,6113370—-337
ALPHATON CAPITAL CORP
SHS NEW
2,072,1030-2,072,1036550—-655
Page 1 of 1
SABBY MANAGEMENT, LLC — 13F Holdings — Q2 2026 | TickerTrail